• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session

    12/15/22 1:28:11 PM ET
    $AGYS
    $ALIT
    $APRN
    $ATXS
    EDP Services
    Technology
    Real Estate
    Real Estate
    Get the next $AGYS alert in real time by email

    Gainers

    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
    • Core Scientific, Inc. (NASDAQ:CORZ) rose 65% to $0.4125. B. Riley Financial issued an open letter to Core Scientific shareholders and lenders.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) shares jumped 58.1% to $0.3711 after declining 4% on Wednesday.
    • Icosavax, Inc. (NASDAQ:ICVX) shares climbed 42.9% to $12.75. Icosavax shares jumped 112% on Wednesday after the company provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against respiratory syncytial virus
    • IMV Inc. (NASDAQ:IMV) surged 34.4% to $2.89 after the company announced initial data from the ongoing Phase 2B VITALIZE trial in patients with r/r DLBCL.
    • Clearmind Medicine Inc. (NASDAQ:CMND) shares jumped 22.3% to $3.8898. Clearmind Medicine’s CEO, Dr. Adi Zuloff-Shani, issued a letter to shareholders.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) rose 18.8% to $9.52. Kintara Therapeutics received orphan drug designation for VAL-083 for treatment of diffuse intrinsic pontine glioma.
    • Lanvin Group Holdings Ltd. (NYSE:LANV) gained 18% to $11.75.
    • Iterum Therapeutics plc (NASDAQ:ITRM) surged 18% to $1.34 after the company announced issuance of allowance for a U.S. patent covering oral sulopenem.
    • Troika Media Group, Inc. (NASDAQ:TRKA) gained 17% to $0.12.
    • Astria Therapeutics, Inc. (NASDAQ:ATXS) rose 15.8% to $12.76. Astria Therapeutics announced preliminary results from the Phase 1a trial of STAR-0215 in healthy subjects.
    • Steakholder Foods Ltd. (NASDAQ:STKH) rose 15% to $0.89.
    • Rallybio Corporation (NASDAQ:RLYB) surged 14.1% to $7.20. Rallybio announced publication of data highlighting the ability of HPA-1a-specific antibodies to prevent alloimmunization in an authentic mouse model of FNAIT.
    • Surrozen, Inc. (NASDAQ:SRZN) shares gained 12.6% to $0.4907. The company, last month, posted a narrower Q3 loss.
    • Agilysys, Inc. (NASDAQ:AGYS) jumped 9.7% to $67.79.
    • Blue Apron Holdings, Inc. (NYSE:APRN) rose 9% to $0.7020 after the company provided an update on funding from Mr. Joseph Sanberg's affiliates. Blue Apron said it received $1 million of the private placement obligation.
    • Sio Gene Therapies Inc (NASDAQ:SIOX) rose 8.8% to $0.3901. On December 14, 2022, the company’s board unanimously approved the dissolution and liquidation of the company pursuant to a plan of complete liquidation and dissolution.
    • Carvana Co. (NYSE:CVNA) gained 8.8% to $5.72. Carvana started offering as-soon-as-next-day touchless home delivery to Corvallis, Oregon, area residents.
    • RCI Hospitality Holdings, Inc. (NASDAQ:RICK) jumped 7.6% to $93.73 folloiwng better-than-expected Q4 results.

     

    Losers

    • Third Harmonic Bio, Inc. (NASDAQ:THRD) shares tumbled 78.3% to $4.3090 after the company announced discontinuation of its Phase 1b study of THB001 in chronic inducible urticaria.
    • Miromatrix Medical Inc. (NASDAQ:MIRO) fell 29.3% to $2.8997. The FDA has placed a clinical hold on Miromatrix Medical’s miroliverELAP Investigational New Drug (IND) application for acute liver failure.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 20.4% to $0.0948. Panbela recently received EMA opinion on orphan designation for Ivospemin in combination with Gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
    • Novavax, Inc. (NASDAQ:NVAX) shares fell 19.8% to $13.81. Novavax proposed an underwritten public offering to sell up to $125 million of its common stock.
    • MicroAlgo Inc. (NASDAQ:MLGO) declined 19.8% to $2.4050.
    • Axcella Health Inc. (NASDAQ:AXLA) dropped 19.3% to $0.72. Axcella Health announced organizational and program updates, including a reprioritization of its programs for Long COVID Fatigue and Nonalcoholic Steatohepatitis (NASH) and a restructuring of operations.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 19% to $0.4170. Vallon Pharmaceuticals shares jumped around 105% on Wednesday after the company and GRI Bio announced they entered into a merger agreement.
    • MicroAlgo Inc. (NASDAQ:MLGO) fell 19% to $2.43.
    • Drive Shack Inc. (NYSE:DS) shares fell 16.6% to $0.2001. Drive Shack shares dropped around 50% on Wednesday after the company announced the intention to voluntarily delist and deregister its securities.
    • Meiwu Technology Company Limited (NASDAQ:WNW) fell 16.5% to $2.1708 after surging 41% on Wednesday.
    • Roblox Corporation (NASDAQ:RBLX) dropped 15.2% to $28.08 after the company reported November 2022 key metrics.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) fell 12.9% to $19.69 after Goldman Sachs initiated coverage on the stock with a Sell rating and announced a $13 price target.
    • Elys Game Technology, Corp. (NASDAQ:ELYS) declined 11.6% to $0.1630.
    • BIMI International Medical, Inc. (NASDAQ:BIMI) fell 10.7% to $2.5263 after climbing 36% on Wednesday. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd.
    • HUYA Inc. (NYSE:HUYA) dropped 10.7% to $3.00.
    • Alight, Inc. (NYSE:ALIT) fell 10.6% to $8.02. Alight, last week, announced the acquisition of ReedGroup.
    • Indaptus Therapeutics, Inc. (NASDAQ:INDP) declined 10.3% to $1.5601.
    • Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) fell 10.2% to $4.33. Checkpoint Therapeutics announced a $7.5 million registered direct offering priced at-the-market under Nasdaq rules.
    • Shore Bancshares, Inc. (NASDAQ:SHBI) declined 8.3% to $17.47. Shore Bancshares and The Community Financial Corporation announced merger of equals to create bank with $6 billion in assets.x
    • NantHealth, Inc. (NASDAQ:NH) dropped 8.6% to $0.2150. NantHealth announced a 1-for-15 reverse stock split.
    • GlycoMimetics, Inc. (NASDAQ:GLYC) shares fell 8.5% to $2.0213.

    Also check this out 5 Most Overvalued Stocks In The Industrials Sector: Aerojet Rocketdyne, Triton International And More.

    Get the next $AGYS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGYS
    $ALIT
    $APRN
    $ATXS

    CompanyDatePrice TargetRatingAnalyst
    Roblox Corporation
    $RBLX
    2/9/2026$84.00Neutral → Buy
    Roth Capital
    Roblox Corporation
    $RBLX
    2/6/2026$159.00 → $105.00Buy
    Needham
    Shore Bancshares Inc
    $SHBI
    2/3/2026$19.00 → $22.00Outperform
    Hovde Group
    Core Scientific Inc.
    $CORZ
    1/6/2026$23.00Neutral → Buy
    BTIG Research
    Core Scientific Inc.
    $CORZ
    12/18/2025$30.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Agilysys Inc.
    $AGYS
    12/17/2025Neutral
    BTIG Research
    Carvana Co.
    $CVNA
    12/15/2025$500.00Buy
    Argus
    Roblox Corporation
    $RBLX
    12/12/2025$100.00Overweight → Neutral
    Analyst
    More analyst ratings

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roblox upgraded by Roth Capital with a new price target

    Roth Capital upgraded Roblox from Neutral to Buy and set a new price target of $84.00

    2/9/26 6:58:32 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Needham reiterated coverage on Roblox with a new price target

    Needham reiterated coverage of Roblox with a rating of Buy and set a new price target of $105.00 from $159.00 previously

    2/6/26 8:28:08 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Hovde Group reiterated coverage on Shore Bancshares with a new price target

    Hovde Group reiterated coverage of Shore Bancshares with a rating of Outperform and set a new price target of $22.00 from $19.00 previously

    2/3/26 6:43:50 AM ET
    $SHBI
    Major Banks
    Finance

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Mcdonald Rebecca Middleton received a gift of 3,075 shares, increasing direct ownership by 2% to 61,927 units (SEC Form 5)

    5 - SHORE BANCSHARES INC (0001035092) (Issuer)

    2/12/26 12:49:20 PM ET
    $SHBI
    Major Banks
    Finance

    Amendment: SEC Form 4 filed by Chief Strategy&ProjectOfficer Pierce Lacey Amanda

    4/A - SHORE BANCSHARES INC (0001035092) (Issuer)

    2/12/26 12:19:22 PM ET
    $SHBI
    Major Banks
    Finance

    Chief Legal Off. & Corp. Sec. Reinstra Mark converted options into 118,110 shares and sold $2,493,475 worth of shares (34,320 units at $72.65), increasing direct ownership by 23% to 454,322 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:57:26 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AGYS
    $ALIT
    $APRN
    $ATXS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Roblox Marks Safer Internet Day With Expanded Safety Partnerships and Commitment to Age-Appropriate Communication

    Roblox's Safer Internet Day Highlights: Introduces New Youth Guide to Community Standards Co-created With Roblox Teen Council Announces New Partnership With the Mental Health Coalition and Joins Thrive Program Reports Strong Early Adoption of Age-Check Requirement, Advancing Civil, Age-Appropriate Experiences and Communication on the Platform Roblox Corporation (NYSE:RBLX), an immersive gaming and creation platform, today, in recognition of Safer Internet Day, reaffirmed its goal to promote safe, positive digital experiences for users of all ages by introducing a new Youth Guide to Community Standards and announcing a new partnership with the Mental Health Coalition. Alongside t

    2/10/26 12:00:00 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Alight Names Solution Leaders for Leaves and Health & Navigation

    Alight, Inc. (NYSE:ALIT), a leading cloud-based human capital and technology-enabled services provider, today announced leadership changes as the company strengthens its commitment to deliver a market‑leading benefits experience for employers and their people across its core solutions in Health, Navigation, Wealth and Leaves. Karen Frost has been appointed Senior Vice President, Health and Navigation Solution Leader, and Kevin Curry has been named Senior Vice President, Leaves Solution Leader, both effective immediately. Together, Frost and Curry will drive aligned go‑to‑market strategies across Alight's health, navigation and leaves solutions, delivering innovative, high-quality service

    2/9/26 4:30:00 PM ET
    $ALIT
    Real Estate

    Roblox Reports Fourth Quarter and Full Year 2025 Financial Results

    Roblox Corporation (NYSE:RBLX) posted a letter to shareholders and supplemental materials containing its fourth quarter and full year 2025 financial and operational results and first quarter and full year 2026 guidance today on the Roblox investor relations website at ir.roblox.com. Earnings Q&A Session Roblox will host a live call to answer questions regarding its fourth quarter and full year 2025 results on Thursday, February 5, 2026 at 1:30 p.m. Pacific Time/4:30 p.m. Eastern Time. The webcast will be open to the public at ir.roblox.com or by clicking here. About Roblox Roblox is an immersive gaming and creation platform that offers people millions of ways to be together, invitin

    2/5/26 4:05:00 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Esham William E. Iii bought $99,950 worth of shares (5,000 units at $19.99) (SEC Form 4)

    4 - SHORE BANCSHARES INC (0001035092) (Issuer)

    2/9/26 12:37:44 PM ET
    $SHBI
    Major Banks
    Finance

    Large owner Tcg Crossover Gp Ii, Llc bought $202,534 worth of shares (9,357 units at $21.65) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/3/26 8:03:54 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Keating Melvin L bought $50,379 worth of shares (600 units at $83.96), increasing direct ownership by 2% to 35,007 units (SEC Form 4)

    4 - AGILYSYS INC (0000078749) (Issuer)

    2/3/26 3:02:52 PM ET
    $AGYS
    EDP Services
    Technology

    $AGYS
    $ALIT
    $APRN
    $ATXS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Astria Therapeutics Inc.

    SCHEDULE 13G/A - Astria Therapeutics, Inc. (0001454789) (Subject)

    2/12/26 4:58:09 PM ET
    $ATXS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Indaptus Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)

    2/12/26 9:30:34 AM ET
    $INDP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Indaptus Therapeutics Inc.

    DEFA14A - Indaptus Therapeutics, Inc. (0001857044) (Filer)

    2/12/26 9:30:18 AM ET
    $INDP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Leadership Updates

    Live Leadership Updates

    View All

    BluSky AI Inc. Appoints Riley Cooney as Corporate Development and Strategy Officer

    Salt Lake City Utah, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BluSky AI Inc. (OTCID: BSAI), a leading developer of prefabricated modular AI infrastructure and Neocloud GPU-as-a-Service infrastructure, proudly announces the appointment of Riley Cooney as its Corporate Development and Strategy Officer. Cooney is a well-respected FP&A and strategic finance executive whose experience includes leadership through a $4B IPO in BTC and Hyperscale infrastructure. Riley has advised on AI and HPC data-center strategy, serving global institutional and Wall Street clients over the past two years. During his five years at Core Scientific (NASDAQ:CORZ), Riley helped scale revenue 24× while growing power capaci

    12/9/25 1:37:56 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    Alight Announces CEO Transition

    Rohit Verma to succeed Dave Guilmette on January 1, 2026 Alight, Inc. (NYSE:ALIT) (the "Company"), a leading cloud-based human capital and technology-enabled services provider, announced that the Company's Board of Directors (the "Board") has appointed Rohit Verma as Chief Executive Officer (CEO) and a member of its Board, effective January 1, 2026. Dave Guilmette will step down as CEO and from the Company's Board on December 31, 2025. "Alight has an over 40-year history as the leading integrated benefits administration services provider with a profound understanding of how to scale the complexity of today's benefits environment," said Russell P. Fradin, Chair of Alight's Board of Directo

    11/24/25 8:00:00 AM ET
    $ALIT
    Real Estate

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Alight Inc.

    SC 13D/A - Alight, Inc. / Delaware (0001809104) (Subject)

    12/10/24 4:00:22 PM ET
    $ALIT
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Alight Inc.

    SC 13D/A - Alight, Inc. / Delaware (0001809104) (Subject)

    12/5/24 4:51:02 PM ET
    $ALIT
    Real Estate

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGYS
    $ALIT
    $APRN
    $ATXS
    Financials

    Live finance-specific insights

    View All

    Shore Bancshares, Inc. Reports 2025 Fourth Quarter and Annual Results

    EASTON, Md., Jan. 28, 2026 /PRNewswire/ -- Shore Bancshares, Inc. (NASDAQ – SHBI) (the "Company" or "Shore Bancshares"), the holding company for Shore United Bank, N.A. (the "Bank") reported net income for the fourth quarter of 2025 of $15.9 million, or $0.48 per diluted common share, compared to net income of $14.3 million, or $0.43 per diluted common share, for the third quarter of 2025, and net income of $13.3 million, or $0.40 per diluted common share, for the fourth quarter of 2024. Fourth Quarter and Full-Year 2025 Highlights Net Income – Net income for the fourth quarte

    1/28/26 4:00:00 PM ET
    $SHBI
    Major Banks
    Finance

    Agilysys Announces 16th Consecutive Record Revenue Quarter: $80.4M in Fiscal 2026 Q3

    Includes Subscription Revenue Growth of 23% Raises Full-Year Fiscal 2026 Total Revenue Guidance to $318M Agilysys, Inc. (NASDAQ:AGYS), a leading global provider of hospitality software solutions and services, today reported results for its Fiscal 2026 third quarter ending December 31, 2025. Summary of Fiscal 2026 Third Quarter Financial Results Total net revenue increased 15.6% to a record $80.4 million compared to total net revenue of $69.6 million in the comparable prior-year period. Recurring revenue (comprised of subscription and maintenance charges) was a record $52.0 million, or 64.7% of total net revenue, compared to $44.4 million, or 63.8% of total net revenue for the sa

    1/26/26 4:05:00 PM ET
    $AGYS
    EDP Services
    Technology

    Carvana to Report Fourth Quarter and Fiscal Year 2025 Results and Host Quarterly Conference Call on February 18

    Carvana (NYSE:CVNA), an industry pioneer for buying and selling cars online, today announced it will report its fourth quarter and fiscal year 2025 financial results for the period ended December 31, 2025, after the market closes on Wednesday, February 18, 2026. On that day, management will hold a conference call and webcast at 5:30 p.m. ET (2:30 p.m. PT) to review and discuss the company's business and results. What: Carvana Fourth Quarter 2025 Financial Results Conference Call When: Wednesday, February 18, 2026 Time: 5:30 p.m. ET (2:30 p.m. PT) Live Call: (833) 255-2830 or (412) 902-6715 An archived webcast of the conferen

    1/21/26 8:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary